These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 8731859)
1. [Hemodynamic and renal effects of strong diuretic atrial natriuretic peptide in patients with acute myocardial infarction]. Wu H; Qian X; Li L Zhonghua Nei Ke Za Zhi; 1995 Dec; 34(12):816-8. PubMed ID: 8731859 [TBL] [Abstract][Full Text] [Related]
2. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure. Lee RW; Raya TE; Michael U; Foster S; Meeks T; Goldman S J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis. La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200 [TBL] [Abstract][Full Text] [Related]
4. Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome. Burnier M; Mooser V; Wauters JP; Marder HK; De Vane P; Nussberger J; Waeber B; Brunner HR J Cardiovasc Pharmacol; 1989 May; 13(5):682-90. PubMed ID: 2472515 [TBL] [Abstract][Full Text] [Related]
5. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure]. La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168 [TBL] [Abstract][Full Text] [Related]
6. Human atrial natriuretic peptide: plasma levels, hemodynamic, hormonal, and renal effects in patients with severe congestive heart failure. Riegger GA; Kromer EP; Kochsiek K J Cardiovasc Pharmacol; 1986; 8(6):1107-12. PubMed ID: 2434734 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of renal but not haemodynamic effects of atrial natriuretic peptide (1-28) in sheep treated with ACTH. Parkes DG; Coghlan JP; McDougall JG; Scoggins BA Clin Exp Pharmacol Physiol; 1988 Dec; 15(12):945-53. PubMed ID: 2854018 [TBL] [Abstract][Full Text] [Related]
8. Attenuated response to atrial natriuretic peptide in rats with myocardial infarction. Kohzuki M; Hodsman GP; Johnston CI Am J Physiol; 1989 Feb; 256(2 Pt 2):H533-8. PubMed ID: 2521777 [TBL] [Abstract][Full Text] [Related]
9. Renal, hormonal, and hemodynamic effects of low-dose infusion of atrial natriuretic factor in acute myocardial infarction. Nakamura M; Arakawa N; Kato M Am Heart J; 1990 Nov; 120(5):1078-85. PubMed ID: 2146863 [TBL] [Abstract][Full Text] [Related]
10. [Acute hemodynamic effects of intravenous recombinant human brain natriuretic peptide in patients with acute myocardial infarction complicated with heart failure]. Li SQ; Fu XH; Liu J; Gu XS; Zhang J; Fan XN; Jiang YF; Miao Q Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):23-7. PubMed ID: 16626544 [TBL] [Abstract][Full Text] [Related]
11. Hemodynamic, renal, and hormonal responses to alpha-human atrial natriuretic peptide in patients with congestive heart failure. Saito H; Ogihara T; Nakamaru M; Hara H; Higaki J; Rakugi H; Tateyama H; Minamino T; Iinuma K; Kumahara Y Clin Pharmacol Ther; 1987 Aug; 42(2):142-7. PubMed ID: 2955995 [TBL] [Abstract][Full Text] [Related]
12. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism. Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502 [TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of human atrial natriuretic peptide after modified Fontan procedure. Hiramatsu T; Imai Y; Takanashi Y; Seo K; Terada M; Nakazawa M Ann Thorac Surg; 1998 Mar; 65(3):761-4. PubMed ID: 9527208 [TBL] [Abstract][Full Text] [Related]
15. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading. Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440 [TBL] [Abstract][Full Text] [Related]
16. Systemic and regional vascular effects of atrial natriuretic peptide in a rat model of chronic heart failure. Drexler H; Finkh M; Höing S; Toth M; Just H; Lang RE Basic Res Cardiol; 1987; 82(6):517-29. PubMed ID: 2963615 [TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide infusion in primary aldosteronism. Renal, hemodynamic and hormonal effects. Rocco S; Opocher G; Carpenè G; Mantero F Am J Hypertens; 1990 Sep; 3(9):668-73. PubMed ID: 2145872 [TBL] [Abstract][Full Text] [Related]
18. Renal and hemodynamic effects of synthetic atrial natriuretic peptide in dogs with chronic renal failure. Tsuchiya K; Sanaka T; Ando A Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):151-7. PubMed ID: 2525634 [TBL] [Abstract][Full Text] [Related]
19. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor. Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440 [TBL] [Abstract][Full Text] [Related]
20. Plasma concentration and renal effect of human atrial natriuretic peptide in nephrotic syndrome. Hisanaga S; Yamamoto Y; Kida O; Kato J; Fujimoto S; Tanaka K Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):661-9. PubMed ID: 2529385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]